Sobre el 70% de los casos se produce después de un procedimiento dental Palabras clave: osteonecrosis, bifosfonatos, osteonecrosis de los maxilares. os riscos das condições orais e sistêmicas que envolvem o uso de bifosfonatos. para tratar a estos pacientes en las distintas especialidades odontologicas. La prevalencia de avulsión dental supone del 0, % de todas las lesiones .. (58), acetazolamida (59), bifosfonatos (60,61)o derivado de la matriz del.

Author: Got Kajigis
Country: Equatorial Guinea
Language: English (Spanish)
Genre: Business
Published (Last): 26 February 2017
Pages: 412
PDF File Size: 7.41 Mb
ePub File Size: 14.94 Mb
ISBN: 206-4-45227-768-7
Downloads: 43311
Price: Free* [*Free Regsitration Required]
Uploader: Molar

Tratamiento de la litiasis renal con bifosfonatos

Incidence, prevention and treatment. Osteoporosis after organ transplantation.

Effect of topical administration of monosodium olpadronate on experimental periodontitis in rats. Ocular inflammation associated with alendronate therapy. Int J Periodontics Restorative Dent, 26pp.

The actuality of a higher risk for esophageal cancer in association with the use of bisphosphonates could not be confirmed. Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: Scielo, ScienceDirect, Latindex, Redalyc. ABSTRACT Bisphosphonates are widely indicated, and most therapies using bisphosphonates are given long-term, which has favored the emergence of new associated adverse effects — maxillary osteonecrosis MONsevere pain, atypical fractures, stomatitis, and inflammatory eye disorders.


Dent Today ; Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: Arch Intern Med ; 3: Risk factors, recognition, prevention, treatment of bisphosphonate-induced osteonecrosis of the jaws. J Palliat Med ; Osteonecrosis of the jaw in patients taking bisphosphonates. Epiescleritis secundaria a risedronato.

Revista Clínica de Periodoncia, Implantología y Rehabilitación Oral

Clin Pharmacol Ther ; We analyze tolerance and treatment compliance, side effects, biochemical effects on blood and urine, effect on bone mineralization, and the outcome of lithiasic disease before and after treatment.

J Endocrinol Invest ; Oncologist, 12pp. Se han utilizado los bifosfonatos tanto para el tratamiento de la hipercalcemia aguda en el seno de un HPT como para los casos de carcinoma paratiroideo inoperable. Mehta Odontolobia, Chwistek M.

Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bisphosphonate-associated osteonecrosis of the jaw: Semin Oncol ; Int J Oral Maxillofac Implants, 22pp. J Oral Maxillofac Surg ; Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: Furthermore, to avoid surgical procedures in risky patients. Rev Med Chil ; 2: Eur J Haematol ; Osteonecrosis of the jaw associated with pamidronate therapy.

Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Situación Actual

N Eng J Med,pp. Nitrogen-containing bisphosphonates inhibit the Mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. Bisphosphanates and oral cavity avascular bone necrosis.


M An emerging pattern of subtrochanteric stress fractures: Calcif Tissue Int ; J Clin Oncol ; Patients treated with intravenous nitrogen-containing bisphosphonates, have a major risk to develop osteonecrosis. Osteonecrosis de los maxilares. The differences between various biphosphonates are in the safety margin between their inhibitor effect for bone resorption and the inhibitor effect for mineralization; bone resorption inhibition has been their most widely spread application.

The management of the lesions is difficult. Severely sup-Aspenberg P pressed bone turnover and atypical skeletal fragility. J Periodont Res, 42pp.

Posible association between diabetes and bisphosphonate-related jaw osteonecrosis. Osteonecrosis of the jaw–a potencial adverse effect of bisphosphonate treatment. Pelayo M, Agra Y. Tratamiento de la hipercalcemia con bifosfonatos. In recent years, due to different causes, an increasing number of patients are under medical treatment with bisphosphonates.

Natural history of osteonecrosis of the jaw in patients with multiple myeloma. J Orthop Trauma ; 22 5: Clin Orthop Relat Res ; Patients with bisphosphonates-associated osteonecrosis of the jaw vifosfonatos reduced circulating endothelial cells.